amphetamine has been researched along with candesartan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bregonzio, C; Cancela, LM; Marchese, NA; Paz, MC | 1 |
| Berk, M; Budni, J; Carvalho, AF; Cavalcante, LM; de Lucena, DF; de Sousa, FC; de Souza Gomes, JA; de Souza, GC; Macêdo, D; Quevedo, J | 1 |
1 review(s) available for amphetamine and candesartan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for amphetamine and candesartan
| Article | Year |
|---|---|
Angiotensin II AT₁ receptors are involved in neuronal activation induced by amphetamine in a two-injection protocol.
Topics: Amphetamine; Animals; Behavior, Animal; Benzimidazoles; Biphenyl Compounds; Brain Mapping; Immunohistochemistry; Neurons; Nucleus Accumbens; Prefrontal Cortex; Proto-Oncogene Proteins c-fos; Rats; Receptor, Angiotensin, Type 1; Tetrazoles; Ventral Tegmental Area | 2013 |
Antimanic-like activity of candesartan in mice: Possible involvement of antioxidant, anti-inflammatory and neurotrophic mechanisms.
Topics: Amphetamine; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antimanic Agents; Antioxidants; Benzimidazoles; Biphenyl Compounds; Bipolar Disorder; Brain; Disease Models, Animal; Drug Evaluation, Preclinical; Lithium Compounds; Male; Memory Disorders; Memory, Short-Term; Motor Activity; Nerve Growth Factors; Random Allocation; Tetrazoles | 2015 |